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Chapter 1: Introduction 
 “The doctor of the future will no longer treat the human frame with drugs, but rather will 
cure and prevent disease with nutrition.”  ~Thomas Edison 
 
“Let food be thy medicine and medicine be thy food.” ~ Hippocrates 
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common behavioral 
disorders in childhood that continues into adulthood (Pelsser, Frankena, Toorman, Savelkoul, 
Pereira, & Buitelaar, 2009).  It is estimated that 1 in 10, or 11%, of children aged 5-17 are 
diagnosed with ADHD (Visser, Holbrook, Danielson, Bitsklo, & Zablotsky, 2015).  Most 
children are diagnosed by age 7, but prevalence of ADHD is higher among older children.  Boys 
are twice as likely to be diagnosed as girls, and non-Hispanic white children are diagnosed more 
often at ages 12-17 than children of other races.  The prevalence of ADHD is higher among 
children whose families have public insurance (Pastor, Reuben, Duran, & Hawkins, & Center for 
Disease Control, 2015).  Long-term risk outcomes of children with ADHD include 
underachievement at school, antisocial personality disorder, delinquency, substance abuse, 
relationship breakdowns, and unemployment (Pelsser et al., 2009). Current professional 
recommendations to treat ADHD include medications and psychosocial interventions (Pelsser  
et al., 2009). These interventions are commonly used because they are easily accessible. 
The treatment of ADHD should not be a one size fits all approach and prescriptions such 
as Adderall, Ritalin, and Concerta can carry high price tags and serious warnings.  The use of 
prescription drugs to treat ADHD can cost a family between $15 a month to $300 per month, 
depending on brand and dosage.  Liquid formulations of the medication can cost as much as 
$500 per month (Consumer Reports Best Buy Drugs, 2012).  Another concern with treating 
ADHD with prescription drugs is the potential for negative side effects such as: reduced appetite, 
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weight loss, change in personality, sudden death, heart attacks, and hallucinations.  Parents and 
some practitioners have been looking for alternative treatments (Parker-Pope, 2008). 
Studies have investigated links between ADHD and nutrition, more specifically whether 
it could be caused by a sensitivity or allergy to additives such as food colorings and 
preservatives, whole foods such as dairy, soy, gluten, eggs, or grains, or a deficit of a specific 
nutrient such as zinc, iron, or B12.  Much of the current United States population consumes a 
diet that can be referred to as a Western Pattern Diet, or Standard American Diet (SAD).  The 
Western pattern and the SAD diet consist primarily of high intakes of refined and processed 
foods, alcohol, salt, red meats, sugary beverages, snacks, eggs, and butter.  Consuming foods 
typically low in potassium and high in sodium, fats, and simple carbohydrates has been 
implicated in many diseases including atherosclerosis, type II diabetes, hypertension, and obesity 
as well as Learning Disorders.  
This paper focuses on how nutrition can affect the ability to learn and contribute to 
ADHD.  It also investigates effective nutritional options which have been tested and 
demonstrated positive results for treating symptoms of ADHD.  This paper reviews findings 
from the additive-free diet, few foods elimination diet, and supplementing nutritional deficits.  
Research Question 
1. What nutritional interventions have been investigated for children and youth to treat 
ADHD? 
2. How effective are nutritional interventions for treating ADHD? 
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Focus of Review 
The review of literature and studies in Chapter 2 include studies with participants who are 
identified as having ADHD with exception to the two food additive studies.  My initial focus was 
to investigate alternative treatment options for treating ADHD.  This focus was broad and 
resulted in a broad range of options.  I chose to narrow my focus on nutrition, more specifically 
on restrictive/elimination diets, and supplementation for treating ADHD.  I chose to focus even 
further to include studies on children not currently taking prescription medications for ADHD 
except for one Omega-3 study. 
The Academic Search Premier database and was used to locate studies, articles, and 
books using a variety of keywords and keyword combinations, including the following: ADHD, 
Attention Deficit Hyperactivity Disorder, diet, restriction diet, Feingold diet, alternative 
treatment, food additives, food sensitivities, gluten free, supplementation, magnesium, iron, red 
ginseng, food colorings, zinc, fatty acids, omega-3, EPA, DHA, L-theanine.  I also searched the 
internet for definitions and statistics regarding ADHD, ADHD prescription cost, and Western 
Pattern and SAD diets. 
Importance of Topic 
Recent studies confirm the influence of diet and nutrition on behavior and learning in 
children and adolescents, particularly with respect to fatty acid supplements and food reactions. 
 As a parent of a child who demonstrates some tendencies of ADHD and as a special 
education teacher, I have come to question what, aside from prescription drugs, can help my 
child or my students focus better in school.  Multiple parents report negative side effects of their 
child’s prescription and have a difficult time enforcing them to take it.  
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 Studies suggest that ADHD symptoms could be the result of or triggered by certain food 
additives, sensitivities, allergies, or deficits.  It is important to explore what foods or deficits 
might contribute to symptoms and what interventions might be helpful in reducing symptoms of 
ADHD.  
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 Chapter 2: Review of Literature 
 Twelve quantitative research studies that investigate nutritional supplements to reduce 
symptoms of ADHD and the association between foods and additives and symptoms of ADHD 
in students are included in the Chapter 2.  Tables 1, 2, and 3 summarize the findings of these 
studies and categorize them by the types of interventions assessed and in chronological order. 
Dietary Supplements 
Vitamins, minerals, and herbs have been studied as a means to improve overall nutrition 
as well as deficits for children and youth with ADHD.  Six studies of supplements are included 
in this section: two on minerals, two on fatty acids, and two herbal. 
Bilici et al. (2004) investigated zinc sulfate in the treatment of ADHD.  The authors 
hypothesize that zinc administration would lead to significantly reduced ADHD symptoms 
compared to a placebo, as measured by the Attention Deficit Hyperactivity Disorder Scale 
(ADHDS), Turkish Adaptation of Conners Teacher Questionnaire (TACTQ), and DuPaul 
Parent Ratings of ADHD (DuPaul).  
 The study consisted of 400 children (72 girls, 328 boys) between the ages of 6 and 14 in 
the first five grades that met the criteria for DSM-IV diagnosis for ADHD by psychiatric 
evaluation.  Exclusions included another axis I disorder, comorbid illness, and any other medical 
conditions.  Participants were randomly assigned to a 1:1 ratio to receive oral zinc sulfate 
(n=202) or placebo (n=198) for a 12-week, double-blind treatment phase.  A fixed-dose  
(150-mg) of zinc sulfate and a placebo (sucrose, 150 mg) were orally administered for a period 
of 12 weeks by mixing it in a breakfast drink.  The dose was kept fixed throughout the duration 
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of the study.  Participants were evaluated to develop a baseline, and then evaluated after week 1, 
week 4, and week 12.  
 The ADHDS, conducted by clinicians, consists of 46 questions that were administered at 
baseline, on week 1, week 4, and week 12 and consists of four subscales: 1) Attention Deficit,  
2) Hyperactivity, 3) Impulsivity, and 4) Impaired Socialization Subscales.  The TACTQ consists 
of three subscales: 1) Attention Deficit, 2) Hyperactivity, and 3) Conduct.  The DuPaul is a 14-
item scale that is different for females and males.  The Connors and DuPaul scales were 
administered twice at the beginning of the study and again at week 12.  
Biochemical and hematological tests were completed twice at baseline and after week 12. 
Each of the participants had to undergo a 12-h fast before a blood sample was collected to 
measure the fatty acids and zinc levels.  Serum Zinc levels were measured using the atomic 
absorption spectrometry (AAS). Free fatty acids (FFA) levels were determined using the 
colorimetric and enzymatic method and by using the Wako commercial kit. 
The Pearson correlation, chi-square, and t test were applied to clinical and laboratory 
safety data for each within-group parameter.  The data gathered from all 400 participants were 
used in assessing the safety of zinc supplementation and data from 95 participants in the zinc 
group and 98 from the placebo group was used to assess efficacy.  At week 12 the zinc group had 
increased levels of zinc compared to baseline (t=12.7, df=96, p=.01) and FFA when compared to 
baseline (t=4.1, df=55, p=.03).  The Pearson correlation showed no connection between BMI or 
age and the ADHDS scores.  
ANCOVA was used to assess the primary and secondary efficacy analyses of the 
differences from baseline to endpoint in mean ADHDS and TACTQ scores between the zinc and 
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placebo groups. The difference between the zinc group and the placebo group was significant 
(F=11.7, df=1,191, p=.002) and was evident at week 4 and maintained through week 12.  The 
mean score of the TACTQ-Hyperactivity subscale was reduced from baseline for the zinc group 
and for the placebo group (F=7.2, df=1,187, p=.03) and the score of the TACTQ-Conduct 
subscale was reduced from baseline for the zinc group and by for the placebo group (F=5.2, 
df=1,187, p=.04).  It was noted the change in mean scores of the TACTQ-Attention Deficit 
subscale and the DuPaul between the two groups were not significantly different. 
On week 4, participants of the zinc group had significant improvement with 
hyperactivity, impulsivity, and impaired socialization symptoms of ADHD when compared with 
the placebo-group; however, there was no positive effect on attention deficit score.  The zinc and 
placebo supplements were both well tolerated by the participants with ADHD.  A metallic taste 
in the mouth was the most frequent complaint for both the zinc supplement and placebo groups. 
Limitations noted of this study include: maintenance of the fixed zinc doses, the short duration of 
the treatment, and the lack of a control group to take a stimulant drug, amphetamine.  
Konofal et al. (2008) carried out a double-blind, placebo-controlled, randomized pilot 
trial of the effects of iron supplementation on attention deficit hyperactivity disorder in children. 
Iron deficiency has been suggested a possible contributing cause of ADHD in children.  
Twenty-three outpatient non-anemic children aged 5-8 years with serum ferritin levels 
<30 ng/mL who met DSM-IV criteria for ADHD and had normal hemoglobin levels were 
selected for the 12-week trial.  Subjects were excluded if they had an IQ<80 by the French 
version of the Wechsler Intelligence Scale, third edition for children, relevant psychiatric 
comorbidities (depressive, anxiety, and sleep disorders per DSM-IV criteria), or chronic medical 
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conditions (including malnutrition).  Children were also excluded who had been taking an iron 
supplement in the past 3 months or previous treatment with psychotropic agents or 
psychostimulants.  
 The subjects who satisfied all the entry criteria were randomized to a ratio of 3:1 in 
blocks of four patients, to either oral iron (ferrous sulfate tablets, 80 mg/day, n=18) or placebo 
tablets (n=5) once daily in the morning for 12 weeks.  The ratio of 3:1 was chosen for ethical 
reasons, being that the selected children had documented iron deficiency.  The study consisted of 
five visits; screening, baseline, and at weeks 4, 8, and 12.  Iron measures were based on several 
measures of biochemical and hematological variables, including serum iron, ferritin, transferrin, 
and soluble transferrin receptors.  Investigators were kept blinded after the screening.  
 The primary outcome measure was the Conners’ Parent Rating Scale (CPRS) which is a 
questionnaire measuring symptoms on a 0-3 scale.  To measure the secondary outcome, the 
Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS), Conners’ Teacher Rating 
Scale (CTRS), Clinical Global Impression-Severity (CGI-S), and iron status measured at 
baseline, and after 4, 8, and 12 weeks of treatment.  At the end of the 12 weeks, the Clinical 
Global Impression-Improvement (CGI-I) subscale score was measured. Patients, parents, 
teachers, and investigators were completely blind to treatment and to biochemical measures 
during the trial. 
 The correlations between serum ferritin levels and ADHD-RS scores were produced 
using Pearson correlation coefficients.  The changes from baseline to weeks 4, 8, and 12 were 
analyzed using parametric (paired Student’s test) or nonparametric (paired Wilcoxon test) 
methods when appropriate for both groups.  Serum ferritin levels increased in the iron treatment 
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group at baseline to week 12 (p=0.000) and levels in the placebo group remained unchanged 
throughout the study.  More improvement was shown in the CPRS in the iron group (p=0.055) 
than the placebo group (p=0.769) and ADHD-RS scores were significantly reduced after 12 
weeks in the treatment group (p=0.008), but not the placebo group (p=0.308).  Similarly, an 
improvement was shown on the CTRS for the treatment group (p=0.076 for within-group 
change) but not in the placebo group.  
 In this study, subjects that participated in the treatment group showed significant 
improvement on the total score of the ADHD-RS as well as on the hyperactivity/impulsive and 
inattentive subscales.  The effect size of the difference between the treatment group and the 
placebo group on the ADHD-RS was large (Cohen’s d=0.81).  CGI-severity and improvement 
scores were also significantly improved in the treatment group but not the placebo group.  The 
CGI-I was not significant between groups.  The iron supplementation was well tolerated by the 
subjects.  Adverse effects reported were: abdominal pain (2 of the 18) and constipation and 
vomiting (1 of the 18).  In the placebo group, abdominal pain was reported in two of the five. 
Limitations of the trial are the small sample size, especially of the placebo group.   
Gustafsson et al. (2010) investigated whether eicosapentaenoic acid (EPA) 
supplementation improves teacher-rated behavior and oppositional symptoms in children with 
ADHD randomized, double-blind study. 
Children aged 7-12 years of age that meet the DSM-IV criteria for ADHD-combined type 
with any neuropsychiatric co-morbidity were eligible.  Exclusions for the study include: IQ<70, 
autism, major depression, epileptic seizure within last 2 years, other neurological disorder, 
endocrinological disorders, fish allergy, severely impaired hearing and vision, severe sleeping 
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disorder, psychotic symptoms or other ongoing medication.  No child had been on stimulants and 
if they were taking a long chain polyunsaturated fatty acid (LCPUFA) supplement they did a 
wash-out period of 10 weeks prior to the study.  Eighty-two children were included in the 15-
week study.  They were randomized to four groups to receive either one capsule daily orally of 
PlusEPA or placebo in a 1:1 ratio. PlusEPA contains 500 mg EPA + 2.7 mg Docosahexaenoic 
acid (DHA) and 10 mg Vitamin E mixed tocopherols.  The placebo was a combination of 
rapeseed oil and medium-chain triglycerides (<10% of PlusEPA content of omega-3 LCPUFA) 
in a capsule identical to the PlusEPA capsule.  
Outcome measures were assessed by parents and teachers using the Conners’ Rating 
Scale (CPRS and CTRS) evaluating three clinical domains: hyperactivity-impulsivity, 
inattention/cognitive problems, and oppositionality.  A doctor and study nurse administered the 
following psychological tests: ADHD-RS to confirm ADHD diagnosis, Raven’s Progressive 
Matrices to assess nonverbal reasoning, and Qb-test to measure hyperactivity.  Blood samples 
were collected to measure PUFA and parents filled out a food frequency questionnaire so that the 
intake of daily energy and fat could be calculated. 
Between-groups comparison was based on the within-subject CPRS + CTRS scores from 
baseline to endpoint analysis was the primary measure.  Mann-Whitney or chi-square were used 
due to distributions not being normal.  Fatty acid was analyzed using a t-test, Kedall’s Tau was 
used to measure correlation and regression.  All comparisons used two-sided statistical tests at 
the 5% significance level.  Bonferroni adjustment for multiple comparisons was performed for 
CPRS and CTRS. 
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On the CPRS and the CTRS, primary efficacy findings variables were essentially 
negative.  Results of the treatment group and the placebo group were found to be similar. 
However, on the CTRS subscale for inattention/cognitive difficulties significant improvement 
was seen in the treatment group.  Due to limited results, a series of post-hoc analysis was 
performed.  Oppositional problems were found to have significantly improved (ES 0.63, 
p=0.026).  The treatment group had a mean improvement score of 12 whereas the placebo group 
had a mean improvement score of 1.5 (ES 0.63, p=0.01).  Oppositional behavior and 
inattention/cognitive problems showed significant improvement but not in hyperactivity for the 
oppositional subgroup, >25% improvement was seen in 52% receiving EPA vs 9% for placebo 
(p=0.001).  The difference in the hyperactivity/impulsivity on the Qb-test was not significant 
between the groups (p=0.177). All of the children demonstrated less hyperactivity/impulsivity 
and oppositional behavior.  
PUFA levels found in serum of both the placebo and treatment group were similar at 
baseline and children who received the PlusEPA showed a 159% increase in their EPA 
concentration and 160% increase in their red blood cell (RBC) at 15 weeks.  PUFA levels 
remained unchanged or decreased in the placebo group.  
The double-blind RCT study, two subgroups of children with ADHD characterized by 
oppositional behavior and less hyperactivity/impulsivity, demonstrated a significant reduction in 
symptoms in the supplementation with EPA group; however, it did not eradicate core 
hyperactivity symptoms.  Improvements were found in inattention/cognitive on the CTRS based 
on behavior in the classroom.  It was found that children that responded to the treatment had 
lower levels of EPA and higher levels of omega-6 at baseline.  Increasing the EPA levels and 
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decreasing the omega-6 levels were related to clinical improvement after 15 weeks of treatment. 
Limitations of the study include: patient selection could be biased as parents that agreed to 
participate might have a more positive interest in alternative treatment and might rate 
improvement unconsciously, an oil with less omega-6/omega-3 might give greater difference 
between treatment and placebo, subgroups were not defined prior to the study but constructed in 
post-hoc analysis, low number of girls participated, dosing was at a low level.  No adverse side 
effects were reported and is considered safe. 
Lee, Lim, and Park (2011) investigated the clinical effects of Korean red ginseng (KRG) 
on attention deficit hyperactivity disorder in children.  Eighteen male subjects aged 6-14 that met 
the DSM-IV criteria for ADHD, had history of psychiatric drug administration, and had visited 
the Dankook University Hospital from August to September, 2010, were selected to participate 
in a single arm open case study for 8 weeks.  
On the first visit, participants of the study were given a physical examination and basic 
history was evaluated on the first visit and a child psychiatrist performed the clinical scales: 
Korean version of Child Behavior Checklist (K-CBCL), Korean Personality Inventory for 
Children (KPI-C), Kovac’s Children’s Depression Inventory (CDI), Spielberger State Anxiety 
Inventory (SAIC), and Spielberger Trait Anxiety Inventory (TAIC) as well as the ADHD 
Diagnostic System (ADS).  Parents completed the Abbreviated Conners Parent-Teacher Rating 
Scale-Revised (CPRS and CTRS) and the Korean version of DuPaul Attention Deficit 
Hyperactivity Disorder Rating Scales (K-ARS).  The same clinical assessments were 
administered on the first visit and repeated at each visit.  On the second visit, participants began 
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the KRG therapy supplied in tablet form containing 500mg of KRG extract to be administered 
half a tablet twice daily.  
Repeated measures t-test was performed to compare results before the KRG medicine and 
at weeks 1, 4, and 8 weeks after administration.  Therapeutic effects reported for ADHD 
symptoms observed through ADS, a significant difference was found in omission error (F=6.3, 
p=0.023) (omission error measures inattention), the Conners ADHD scale showed a significant 
difference in the score (F=4.89, p=0.042), the K-CBCL a significant score was not found in all 
subscales, the KPI-C a significant score reduction was found in the physical development scale 
(F=7.07,p=0.017) and social relations scale (F=6.15, p=0.025).  The only adverse effect reported 
by participants was the bad taste.  Limitations of the study include: small sample size without 
controls, the clinical responses to KRG found cannot be generalized for the entire ADHD 
population.  
Ko et al. (2014) investigated the effects of Korean red ginseng (KRG) extract on behavior 
in children with symptoms of inattention and hyperactivity/impulsivity.  There is evidence that 
KRG can reduce the production of the adrenal corticosteroids, cortisol, and 
dehydroepiandrosterone (DHEA), and thus may be a viable treatment option for ADHD.  A 
single-center, double-blind, randomized, placebo-controlled trial was performed in a tertiary care 
academic hospital in Daegu, Korea, to evaluate whether red ginseng treatment improved 
attentiveness and adrenal function in children with chronic stress.  Seventy-two children met the 
inclusion criteria of being aged 6-15, having more than six symptoms of inattention or 
hyperactivity/impulsivity that are diagnostic criteria for ADHD DSM-IV.  Exclusion criteria of 
taking drugs that could affect psychological symptoms limited the number patients so the study 
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was opened to include ADHD-NOS (not otherwise specified).  All patients had symptoms for 
more than 6 months and had morning salivary cortisol levels less than 10 ng/mL, which is 
considered to indicate chronic stress.  Exclusions applied if the subjects were taking drugs that 
could affect psychological symptoms, including antipsychotic drugs; common cold drugs such as 
amphetamine, ephedrine, and ginseng products; or vitamin supplements.  Subjects were also 
excluded if they had adrenal or thyroid disease, or if they had a psychological diagnosis with the 
preceding 3 months.  The subjects were assigned randomly 1:1 to KRG treatment group 
(n=35) or control group (n=37).  During the study, saliva samples were not collected for two 
subjects in the KRG group so they were excluded.  The final study population consisted of 70 
subjects KRG group (n=33) and control group (n=37). 
A 2-week screening period allowed analysis of demographic data, past medical history, 
medication use, and vital signs of each subject.  Following week 2, they were randomly assigned 
in a double blind manner to receive one pouch (40 mL) of KRG extract twice a day or one pouch 
(40 mL) of an identically flavored and packaged placebo twice a day.  All participants, care 
providers, and those assessing were blinded after assignment to interventions.  The study 
duration was 8 weeks with evaluations at baseline, 4 weeks, and 8 weeks after treatment 
assignment.  Subjects were assessed using 18 questions pertaining to DSM-IV diagnostic criteria 
and parents and/or teacher completed a questionnaire to assess the subject's symptoms of 
inattention or hyperactivity/impulsivity, and Quantitative Electroencephalography Theta/Beta 
Ratio (QEEG-TBR) was performed. 
The KRG treatment group and the control group were compared in terms of baseline 
characteristics by using Pearson’s chi-square test or independent t test.  The KRG groups mean 
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scores decreased from 6.39 at baseline to 4.03 at week 8 (p<0.001) and the control group also 
decreased from 5.70 to 4.57, (p=0.002) which is not statistically significant (p=0.391).  However, 
when adjusted using the Bonferroni correction the KRG group showed a greater decrease in 
inattention scores after 8 weeks than the control group showing that the difference was 
statistically significant with a medium effect size (p=0.048, Cohen’s d=0.47).  The hyperactivity 
scores at 8 weeks between the groups showed statistically significant difference (p=0.019) and 
when adjusted using the Bonferroni correction the difference is significantly greater in the KRG 
group when compared to the control group (p=0.047, Cohen’s d=0.49) which is a medium effect 
size.  Salivary cortisol and DHEA levels increased in both groups and significant between-group 
differences were not observed.  The QEEG TBR decreased from 3.79 to 2.85 (p=0.001) in the 
KRG group and from 3.74 to 3.63 (p=0.126) in the control group.  The Bonferroni adjustment 
showed that the KRG group had a significantly greater decrease in QEEG TBR with a large 
effect size (p=0.001, Cohen’s d=1.13).  
It was found that KRG extract significantly improved the inattention and 
hyperactivity/impulsivity symptoms and QEEG-TBR of the subjects and had a good safety 
profile; however, it did not have significant effects of cortisol and DHEA levels of chronically 
stressed children with ADHD symptoms.  One KRG subject reported loose stool and two in the 
control group reported nausea unrelated to the placebo.  The two groups did not differ 
significantly in terms of frequency of adverse events (p=0.494).  The results suggest that KRG 
extract may be an effective and safe alternative treatment for children with inattention and 
hyperactivity/impulsivity symptoms. 
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Bos et al. (2015) conducted a 16-week, double-blind randomized, placebo-controlled trial 
to investigate whether dietary omega-3 fatty acid supplementation in boys with and without 
attention deficit/hyperactivity disorder would improve symptoms of inattention.  Omega-3 PUFA 
is thought to play an important role in cognitive control.   
A total of 40 boys aged 8-14 years of age with a DSM-IV diagnosis of ADHD were 
recruited through the University Medical Center in Utrecht, Netherlands, and through 
advertising.  Only boys were chosen to limit potential confounds (such as gender) on brain 
activity.  The children with ADHD were either not taking medications or using psychostimulant 
medication.  A total of 39 typically developing boys matched to patient’s age, hand preference, 
and body mass index were recruited as a reference group through advertising at schools in the 
area.  All subjects were screened and none of the typically developing subjects were taking any 
form of psychoactive medication.  Parents participated in a Diagnostic Interview Schedule for 
Children-Parent Version (DISC-P) interview to confirm the absence of any psychiatric condition 
and their first-degree relatives. 
All subject’s IQ were assessed using a short form of the Wechsler Intelligence Scale for 
Children (WISC-III).  The children with ADHD had a slightly lower IQ score than the typically 
developing children.  Hand preference was assessed using the Edinburgh Handedness Inventory. 
Cheek cell samples were assessed to measure phospholipid fatty acid (PUFA) levels and urine 
samples were collected to measure the HVA to creatinine ratio, as a proxy for dopamine 
turnover.  The Essential Fatty Acid Questionnaire (EFAQ) was collected to assess symptoms of 
FA deficiency.  The parent-rated Child Behavior Checklist (CBCL) and Strengths and 
Weaknesses of ADHD symptoms and Normal behavior scale (SWAN) were collected for all 
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participants, both of which measure the severity of ADHD symptoms.  The CBLC (collected 
twice) was used as the primary outcome measure, whereas the SWAN (collected five times) was 
used to measure change over time.  The Teacher Report Form (TRF) was sent out to classroom 
teachers at baseline and follow-up.  The fMRI was performed SPM8 and scans were excluded if 
head motion exceeded 3mm.  Thirteen children with ADHD and six typically developing 
children were excluded from the SPM fMRI analysis. 
The 16-week trial followed a double-blind, randomized placebo-controlled design where 
investigators, parents, and participants were all blind to the treatment conditions.  The 2x2 
factorial design included four groups: children with ADHD receiving either placebo or omega-3 
fortified margarine (ADHD-Placebo and ADHD-Active) and children from the reference group 
receiving the same treatment (RG-Placebo and RG-Active).  All participants were instructed to 
consume a daily dose of 10 g of either normal or omega-3 fortified margarine.  The active 
product was full fat (80%) margarine, containing 650 mg DHA and 650 mg EPA per 10 g 
serving.  The placebo margarine contained monounsaturated fatty acids instead of EPA and 
DHA.  Compliance was measured by weighing the leftover product that the parents returned on a 
monthly basis.  Participants and parents kept a calendar to record when the margarine was 
consumed.  They were asked to maintain their usual diet but to refrain from supplements 
containing omega-3 or foods fortified with EPA and DHA, nor were they to consume fatty fish 
more than once a week.  Compliance was measured using the Diet and Lifestyle Change 
Questionnaire on monthly basis.  
Behavioral and psychological measures were analyzed using independent samples t-tests 
or Mann-Whitney U-tests at baseline between the diagnostic groups, and between the 
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intervention groups.  To investigate treatment effects, all variables of interest were analyzed 
using ANCOVA with the baseline measurement entered as a covariate.  
ANCOVA showed a main effect of treatment condition where attention problems were 
greatly reduced after supplementation in comparison to the placebo group ((F(1,67)=14.99, 
p,0.001).  No significant effects were in rule breaking and aggressive behavior.  
 Supplementation of Omega-3 PUFA improved symptoms of inattention in both groups of 
boys, those with ADHD and those typically developing.  At baseline, boys with ADHD had 
higher symptoms of inattention than boys that are typically developing.  There was an effect of 
treatment on parent-rated symptoms of ADHD, regardless of diagnosis.  This effect was driven 
by the measures of inattention at follow-up: subjects who had received the omega-3 PUFAs had 
lower scores on the CBCL attention problems subscale than subjects on the placebo.  The results 
of this study indicate that typically developing children also benefit from omega-3 PUFA intake 
during development in general.  Cheek cell phospholipids had increased levels of omega-3 
PUFAs and DHA at follow-up for subjects treated with the active product than for those treated 
with the placebo.  Subjects with ADHD with higher levels of DHA were associated with lower 
attention problems both at baseline and at follow-up.  Limitations of this study include: cheek 
cell samples did not permit reliability detection of DHA; however, this did not affect the 
statistical analyses negatively; a small number of participants with ADHD had changes made to 
their medication during the intervention; however, when the subjects were excluded from 
analysis the effect of the intervention still held; sample sizes in the fMRI study were smaller than 
in the main study as a result of subject motion. 
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Table 1: Summary of Nutritional Supplements 
AUTHORS STUDY 
DESIGN 
PARTICIPANTS PROCEDURE FINDINGS 
Bilici, 
Yıldırım, 
Kandil, 
Bekaroğlu, 
Yıldırmış, 
Değer,Ülgen, 
Yוldrוran, & 
Aksu (2004) 
Quantitative 400 children that 
met DSM-IV 
criteria for ADHD  
12 weeks of double-
blind treatment with 
Zinc Sulfate (150 
mg/day) or placebo. 
Results were gathered 
through the use of the 
Attention Deficit 
Hyperactivity Disorder 
Scale (ADHDS), 
Conners Teacher 
Questionnaire, and 
DuPaul Parent Ratings 
of ADHD 
Zinc sulfate was 
significantly superior to 
the placebo group in 
reducing hyperactivity, 
impulsive and impaired 
socialization symptoms, 
but not attention 
deficiency symptoms, as 
assessed by ADHDS, in 
older patients and in 
patients with high BMI 
score.  
Konofal, 
Lecendreux, 
Keron, 
Marchand, 
Cortese, Zaїm, 
Mouren, & 
Arnulf (2008) 
Quantitative 23 nonanemic 
children aged 5-8 
years with serum 
ferritin levels <30 
ng/mL and who 
also met DSM-IV 
criteria for ADHD 
The children were 
randomized (3:1 ratio) 
to either oral iron or 
placebo for 12 weeks. 
The ADHD Rating 
Scale and the Conners’ 
Parent and Teacher 
Rating Scales were used 
to measure symptoms. 
Significant 
improvement in 
symptoms noted on all 
the rating scales for the 
individuals taking the 
iron supplement but not 
for the placebo group. 
May be a beneficial 
intervention if children 
have low serum ferritin 
levels. 
Gustafsson, 
Birberg-
Thornberg, 
Duchén, 
Landgren, 
Malmberg, 
Pelling, 
Strandvik, & 
Karlsson 
(2010) 
Quantitative 92 children aged  
7-12 that met 
DSM-IV criteria 
for ADHD 
combined type 
Children were 
administered PlusEPA 
(500 mg + 2.7 mg DHA 
and 10 mg Vitamin E) 
or an identical placebo 
of rapeseed oil for 15 
weeks.  
Conners’ Parent/ 
Teacher Rating Scale, 
ADHD-RS, Raven’s 
Progressive Matrices, 
Qb-test and serum and 
blood levels. 
Significant reduction of 
ADHD symptoms was 
reported in the EPA 
group. 
Inattention/cognitive in 
the classroom was 
improved for the teacher 
rating. 
Children responding to 
the treatment initially 
had low levels of EPA. 
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Table 1 (continued) 
AUTHORS STUDY 
DESIGN 
PARTICIPANTS PROCEDURE FINDINGS 
Lee, Lim, & 
Park (2011) 
Quantitative 18 subjects aged  
6-14 that met 
DSM-IV criteria 
for ADHD 
KRG (1000 mg twice 
daily) was administered 
for 8 weeks and 
efficacy was measured 
using ADS, CPRS, 
CTRS, DuPaul ADHD 
Rating Scales, Kovac’s 
CDI, SAIC, TAIC, K-
CBCL, and KPI-C. 
The KRG treatment 
showed improvement in 
inattentiveness in 
children with ADHD 
but not the general 
severity of ADHD, 
depression, anxiety 
personality and 
behavioral changes. 
Ko, Kim, Kim, 
Moon, Whang, 
Lee, & Jung 
(2014) 
 
Quantitative 70 subjects aged  
6-15 that had six or 
more symptoms of 
inattention or 
hyperactivity/impul
sivity from DSM-
IV for ADHD as 
well as ADHD 
NOS 
Subjects were 
administered a pouch 
containing 40 mL of 
KRG or identical 
placebo twice daily for 
8 weeks.  
Inattention and 
hyperactivity/impulsive
ness scale 
questionnaire, saliva 
samples, and QEEG 
used to measure the 
efficacy of the KRG 
treatment. 
Inattention and 
hyperactivity/impulsive
ness scores showed a 
significant improvement 
in the treatment group 
when compared to the 
control group.  
There were no 
significant differences 
between groups for 
Salivary cortisol and 
DHEA levels. 
The KRG group showed 
a significantly greater 
decrease in their QEEG 
TBR. 
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Table 1 (continued) 
AUTHORS STUDY 
DESIGN 
PARTICIPANTS PROCEDURE FINDINGS 
Bos et al. 
(2015) 
Quantitative 40 boys aged 8-14 
that meet DSM-IV 
criteria for ADHD. 
39 typically 
developing boys 
were included as a 
reference group. 
Participants 
included both, not 
taking medication 
and taking 
psychostimulant 
medication. 
Only boys were 
included to reduce 
potential confounds on 
brain activity. 
Participants received a 
daily dose of either 
placebo 10 g or omega-
3 fortified margarine 10 
g (containing 650 mg 
DHA and 650 mg EPA) 
for 16 weeks. All 
participants, 
investigators and 
parents were blind. 
Fatty acid levels were 
checked by cheek swab 
and EFAQ. CBCL, 
SWAN, TRF, and fMRI 
were used to evaluate 
efficacy.  
 
Symptoms of inattention 
were improved in both 
the boys with ADHD 
and the boys typically 
developing. 
It was found to improve 
inattention more 
specifically than general 
ADHD symptoms. 
Cheek cells showed 
higher levels of DHA at 
the end of the study. 
Subjects with ADHD 
with higher levels of 
DHA were associated 
with lower attention 
problems. 
 
Food Additives 
Artificial food colors and other food additives (AFCA) have long been 
suggested to affect behavior in children.  Known effects of AFCA is producing overactive, 
impulsive, and inattentive behavior, or hyperactivity.  Children that exhibit this pattern of 
behavior to a large degree are probably diagnosed with ADHD (McCann et al., 2007).  Two 
studies have been included in this section. 
Bateman et al. (2004) studied the effects of a double blind, placebo controlled, artificial 
food colorings, and benzoate preservative influence on hyperactivity in a general population 
25 
 
sample of preschool children.  The authors hypothesize that food additives have a 
pharmacological effect on behavior regardless of other characteristics of the child.  
 Two hundred seventy-seven children were selected for the 4-week study.  The children 
were 3 years old and underwent screening of behavior using the Weiss-Werry-Peters Activity 
Scale (WWP) and the Behavior Checklist (BCL) to measure hyperactivity and skin prick testing 
for reactivity to common allergens: dust mites, grass pollen, cat, milk, egg, and peanut. 
Following the screening the children were divided into four groups for a randomized, double- 
blind, placebo-controlled, crossover study.  The groups were hyperactive and atopic, non-
hyperactive but atopic, hyperactive but not atopic, and non-hyperactive and nonatopic.  The  
4-week study consisted of the children following an artificial coloring and a sodium benzoate 
free diet.  On weeks 2 and 4 the children consumed daily a juice containing 300 mL of mixed 
fruit juices (placebo or active) in identical bottles.  The active drink contained 20 mg of artificial 
food colors (sunset yellow, tartrazine, carmoisine, and ponceau 4R; 5 mg of each) and 45 mg of 
sodium benzoate. E ach week research psychologists assessed the children’s behavior during free 
periods and structured tasks to measure inattention, activity, and impulsivity. 
 ANOVA analysis and repeated measures analysis of variance were used to measure 
effects of the challenges.  The effect of food additives and colorings on hyperactivity for the 
parent rating was substantial.  The parent rating of hyperactivity while on the placebo was 0.38 
and for the active supplement was 0.77.  The difference of 0.39 between the 2 changes is 0.39 
and represents an effect size of 0.51.  The removal of food additives and colorings from the diet 
had a beneficial effect as measured by parents but not by clinical assessments.  No significant 
changes in tests scores for either the active or placebo periods were seen by clinical measures; 
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however, parental ratings showed significant changes between the active and placebo periods. 
During the active period they indicated a significant increase in hyperactivity behavior, as well 
as aggregate parental hyperactivity rating but not for impulsivity and inattention.  A limitation of 
the study is that the parents of the children participating in the study could not be blinded to the 
removal of food additives and colorings. 
McCann et al. (2007) investigated the effects of food additives on hyperactive behavior in 
3-year-old and 8/9-year-old children by designing a community based, double-blinded, placebo-
controlled food challenge to determine whether the effects could be seen with a broad range of 
measures of hyperactivity. 
Participants for the study were recruited from early-years settings for the children aged 3 
years to 4 years, 2 months (n=153, boys=79, girls=74) and from children aged 8 and 9 (n=144, 
boys=75, girls=69) attending schools in Southampton, UK.  The sample study includes children 
from a full range of socioeconomic backgrounds.  Participating schools and early-childhood 
settings received contributions towards school funds.  
The study design and protocols for age groups are similar and consisted of a within-
subject crossover between two active mixes (A and B) and a placebo drink.  For the 3-year-old 
group, mix A consisted of 20 mg of artificial food colorings (5 mg sunset yellow, 2.5 mg 
carmoisine, 7.5 mg tartrazine, and 5 mg of ponceau 4R) and 45 mg of sodium benzoate.  Mix B 
included 30 mg of artificial food colorings (7.5 mg sunset yellow, 7.5 mg carmoising, 7.5 mg 
quinoline yellow, and 7.5 mg allura red AC) and 45 mg sodium benzoate.  The amounts in the 
mixes were multiplied by 1.25 for the 8/9-year-old group.  Mix A contained 24.98 mg of 
artificial food colorings (6.25 mg sunset yellow, 3.12 mg carmoisine, 9.36 mg tartrazine, and 
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6.25 mg of ponceau 4R) and 45 mg of sodium benzoate.  Mix B included 62.4 mg of artificial 
food colorings (15.6 mg sunset yellow, 15.6 mg carmoisine, 15.6 mg quinoline yellow, and 15.6 
mg allura red AC) and 45 mg sodium benzoate.  Dosages of the mixes A and B administered to 
the 3-year-old group were roughly the same as the amount of food coloring in two 56g bags of 
sweets.  For the 8/9-year-old group, mix A was equal to about two bags of sweets and mix B was 
equal to about four bags of sweets a day.  
Baseline data were gathered after a week on their typical diet at week 0 and then artificial 
colors and sodium benzoate that was to be used in the study were withdrawn from their diet for 
the 6 weeks of the study.  Week 1: withdrawal period but receiving placebo; weeks 2, 4, and 6: 
challenge with random assignment to two active periods and one placebo period; weeks 3 and 5: 
washout continuing placebo.  During this period, the 3-year-old group received the challenge and 
washout-placebo drink on a weekly basis and consumed mixed fruit juices (placebo or active) at 
home (300 mL/day for 3-year-old children, 625 mL/day for 8/9-year-old children. 
All the preparation and packaging of juice drinks were done by administration and 
delivered to homes every week by the blinded research team and questionnaires and other forms 
were obtained and dispensed.  Parents recorded juice consumption and compliance daily. 
Three measures of behavior were used to calculate Global Hyperactivity Aggregate 
(GHA) for 3-year-old with an additional measure for the 8/9-year-old group.  The teacher 
version of an abbreviated ADHD rating scale IV, an abbreviated version of the Weiss-Werry-
Peters (WWP) hyperactivity scale was completed by parents and a parent version of an 
abbreviated ADHD rating scale IV was used with the 8/9-year-old group, and classroom or early 
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childhood setting observations were used to evaluate all the participants.  A fourth measure for 
the 8/9-year-old group was the Conners Continuous Performance Test II (CPTII).  
The age groups were measured and treated as independent parallel studies.  Linear 
mixed-model methods were used to analyze data:  Model 1 measured the fixed effect testing for 
mix A against placebo and mix B against placebo.  Model 2 adjusted the effects of the following 
factors: week during study, sex, GHA in baseline week, number of additives in pretrial diet, 
maternal education level, and social class.  A compound symmetry covariance matrix was the 
best-fit for measuring the 3-year-old group and an unstructured covariance matrix was used for 
the 8/9-year-old group. 
Of the 153 3-year-old participants, 117 had complete GHA data, many of them did not 
consume all the drinks required.  Model 1, the results on all three samples had significant 
adverse effects of mix A on GHA compared to the placebo but the high GHA scores for mix B 
were not significantly greater than for the placebo.  For Model 2, the effect of mix A was 
significant for the entire sample (p=0.044), by contrast with that of mix B (p=0.093).  When 
analyses are restricted to those children that consumed at least 85% of the juice (n=103), the 
adverse effect of mix A was still significant (p=0.016), but not significant for mix B (p=0.098). 
The complete case groups showed the same pattern of results (mix A, p=0.020; mix B, p=0.131).  
Of the 144 8/9-year-old participants, 114 had full GHA data during active and placebo 
weeks.  For Model 1 the effects of mix A and mix B were significantly greater than that of the 
placebo, with the exception of the entire sample in which the effects of mix A versus the placebo 
fail to reach significance.  Model 2, the effect of mix A for the entire sample was not significant 
(p=0.123) but mix B did have a significantly adverse effect compared with the placebo 
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(p=0.012).  When analyses are restricted to those children that consumed at least 85% of the 
juice (n=98), the adverse effect of mix A remained non-significant (p=0.066), but was significant 
for mix B (p=0.003).  The complete case groups showed higher GHA scores than the placebo for 
mix A (p=0.0.23) and mix B (p=0.001).  
This study has found the effects of a mix of additives commonly found in children's food 
increases the mean level of hyperactivity in children aged 3 years and 8/9 years old and provides 
evidence of adverse effects of AFCA on children’s behavior.  The findings of this study are seen 
not only in children with extreme hyperactivity (ADHD) but in the general population and across 
the range of severities of hyperactivity. 
Table 2: Summary of Food Additives 
AUTHORS STUDY 
DESIGN 
PARTICIPANTS PROCEDURE FINDINGS 
Bateman et al. (2004) Quantitative 277 3-year-old 
children 
Child followed an 
artificial coloring and 
sodium benzoate free 
diet. Weeks 2 and 4 
the children 
consumed a juice 
containing 300 mL 
of mixed fruit juices 
(placebo or active). 
The active drink 
contained 20 mg of 
artificial food colors 
and 45 mg of sodium 
benzoate. Children 
were evaluated 
weekly. 
Significant 
reductions of 
hyperactivity 
during the 
withdrawal 
periods and 
significant 
increases of 
hyperactivity 
behavior during 
the active period 
vs. placebo on 
parent ratings. 
Clinical ratings 
showed no 
significant 
difference. 
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Table 2 (continued) 
AUTHORS STUDY 
DESIGN 
PARTICIPANTS PROCEDURE FINDINGS 
McCann et al. (2007) Quantitative 137 3-year-old 
participants 
130 8/9-year-old 
participants 
Two active mixes 
containing different 
quantities of artificial 
colorings and 
additives commonly 
found in children's 
foods (A and B) and 
a placebo drink. 
The Weiss-Werry-
Peters hyperactivity 
scale, classroom 
observation code, 
and Conners 
Continuous 
Performance test II 
was used as a 
measure for the 8/9 
year olds. 
When the 3-year-
old children 
consumed the 
mix A they saw 
significant 
adverse effects 
compared to the 
placebo but not 
in mix B. 
 
The 8/9-year-old 
group displayed 
significant 
adverse effects 
after consuming 
both mix A and 
mix B compared 
to the placebo. 
 
 
Restricted Elimination Diet 
The elimination diet, also known as the restricted elimination diet (RED), for the 
following studies is based on a few foods diet.  The idea behind the few foods diet is that 
children might demonstrate ADHD symptoms after eating certain foods.  The diet consists of a 
limited number of hypoallergenic foods such as: rice, turkey, lamb, a range of vegetables 
(lettuce, carrots, cauliflower, cabbage and beet), pears, and water.  No other foods were allowed 
but the foods from the few foods diet were allowed every day in normal doses.  Non-dairy 
calcium was supplemented daily.  Complementary foods such as: potatoes, fruits, corn and wheat 
were allowed on days and in doses outlined in advance according to an intake schedule.  
Pelsser et al. (2009) conducted a randomized controlled trial into the effects of food on 
ADHD to assess the efficacy of a restricted elimination diet in reducing symptoms in children.  
31 
 
Seventy-nine Dutch children were referred to the ADHD Research Center and 27 were 
selected to participate in the study.  They were aged 3.8-8.5 years old and met DSM-IV criteria 
for Combined Type or Hyperactivity-Impulsive Type.  Exclusion criteria included: adopted or 
foster children, coexisting neurological disease, an IQ below 70, prematurity or dysmaturity, use 
of alcohol or smoking by mother during pregnancy, and coexistence of other psychiatric 
disorders, except for oppositional defiant disorder (ODD) and conduct disorder (CD).  None of 
the children used psychotropic medication. 
 Primary outcomes were measured using parent and teacher ratings on the Abbreviated  
10-item Conners Scale (ACS) and the ADHD Rating Scale (ARS) before and after the 
elimination diet.  Secondary outcomes were measured using parent ratings on ODD symptoms 
measured by a Structured Psychiatric Interview (SPI). The parents and teachers who filled in the 
questionnaires were not blinded as they had to supervise the food intake. 
Data were analyzed on an intention-to-treat basis, effect size were % scale reduction and 
Cohen’s d.  Effects were tested at p=0.05; all testing was two-tailed.  Data were analyzed by 
Student’s t test and Fisher’s exact test. 
Results for after the trial revealed that the intervention group showed a 62.6% 
improvement on the ACS and a 70.3% improvement on the ARS (p<0.001).  The children in the 
intervention group also demonstrated significantly decreased behavior problems in comparison 
children in the control group.  The treatment of effect of the ARS for inattention between the 
intervention and control group (mean difference 11.8, p<0.001) and hyperactivity//impulsivity 
(mean difference 14.1, p<0.001).  The parent rating showed that 11/13 children in the 
intervention group showed an improvement of 50% or more and none of the children in the 
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control showed an improvement of 50% or more.  Teacher measures also show a significant 
difference between intervention and the control group for inattention (mean difference 8.3, 
p<0.011) and hyperactivity/impulsivity (mean difference 12.8, p<0.002).  
Restricting and carefully supervising foods in children has shown significant 
improvement in behavior.  It was noted that responders (parent rating, 11 out of 15, 73%) 
(teacher rating, 7 out of 10, 70%) of the intervention group no longer met the DSM-IV criteria 
for ADHD.  Eighty percent of the children in the intervention group also met the criteria for 
ODD and 83% in the control group.  Following the intervention, the number of children that met 
the criteria for ODD was reduced by 66% for the intervention group but no effect was shown for 
ODD in the control group.  Limitations include: no placebo and parents and teachers were not 
blinded to the intervention.  
Pelsser, Frankena, Buitelaar, and Rommelse, (2010) studied the effects of food on 
physical and sleep complaints in children with ADHD.  They conducted a randomized controlled 
pilot study to: 1) examine whether the physical and sleep complaints could be resolved using an 
elimination diet; 2) investigate whether the effect of a diet on physical and sleep complaints was 
limited to children that had improvements in behavior on a RED; and 3) investigate whether 
effects of an RED on physical and sleep complaints was limited to children with an allergy. 
 Twenty-four children completed the study after meeting the inclusion criteria of being 
aged 3-8 years old; met DSM-IV criteria for ADHD combined type or hyperactive-impulsive 
type, behavior problems were evident before age 4, and not on medication.  Exclusions include: 
diagnosed with autism spectrum disorder, pre- or dysmature at birth, or maternal smoking during 
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pregnancy.  The participating children were randomly assigned to the diet group (n=13) or the 
control group (n=11).  
Physical and sleep complaints were measured by Physical Complaints Questionnaire 
(PCQ) that was completed by parents once after baseline and again when the study ended.  The 
physical complaints measured by the assessment include: 1) pain (headaches, abdominal pains 
and growing pains), 2) unusual thirst or perspiration, 3) eczema, 4) asthma or persisting cold 
(rhinitis), 5) skin problems (blotches in the face, red ears, red-edged mouth or bags under the 
eyes, 6) tiredness, and 7) gastrointestinal problems (diarrhea, constipation and flatulence). 
After random assignment, all the participants started a 2-week baseline diet or eating as 
normal; no foods were eliminated.  Parents kept a journal of their child’s diet, behavior, physical 
complaints, sleep complaints, and activities.  Following the baseline period, children in the diet 
group began their diet consisting of foods included in the few foods diet with complementary 
foods allowed as allocated on the schedule for 5 weeks.  If no improvements were noted by the 
end of week 2, diets were restricted further to only the few foods diet.  The control group 
continued their normal diet so that no foods were excluded for 5 weeks.  
Differences in averages within groups of the parent ratings on the PCQ before and after 
the trial were tested by Student’s t test and expressed by Cohen’s d.  Differences in presence or 
absence of complaints between the groups are presented in terms of odds ratio (OR) and their p 
values.  Following the trial, all the children (n=11) in the control also completed the RED. 
Secondary endpoints analyzed using linear and exact logistic regression and calculated in all 24 
children who completed the diet.  Responders, refer to the children that showed a reduction in 
ADHD symptoms of 50% or more following the diet and non-responders, refer to the children 
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that showed less than 50% reduction of ADHD symptoms while on the diet.  Spearman rank 
correlation coefficients were calculated to evaluate the physical complaints and ADHD 
symptoms after following the diet. 
The total number of complaints at the start of the trial was 44 and was reduced to 10 
complaints at the end for the diet group.  This is a reduction of 77% (p<0.001) with an effect size 
of 2.0.  The control had 36 complaints at the start of the trial and 30 at the end showing a 
reduction of 17% (p<0.08) with an effect size of 0.2.  The OR scores of the presence/absence of 
symptoms for three domains are: 1) headaches or bellyaches (OR=13.25), 2) unusual thirst or 
unusual perspiration (OR=10.04), and 3) sleep complaints (OR=11.77).  The complaints were 
significantly reduced in the diet group and less so in the control group (p<0.05).  Responders, 20 
of 24, showed an average reduction of 69.4% on the ARS (effect size 2.1) parent ratings there 
was reduction of 70.6% (effect size, 2.5) for teacher ratings.  The responder group showed a 
significant reduction of physical complaints (p<0.001); the non-responder group, the reduction 
was not significant (p=.35), with effect sizes of 1.4 and 0.8.  Spearman’s rho was 0.54 (p<0.01), 
indicating there was a positive correlation between the reduction of physical and behavioral 
symptoms.  The reduction of physical complaints for atopic children as well as non-atopic 
children was significantly reduced after the diet. 
It is common for children with ADHD to also have physical complaints such as 
headache, bellyache, tiredness, eczema, and sleep complaints.  In this study, the intervention 
significantly reduced the ADHD symptoms.  The report that the results indicate that comorbidity 
between ADHD and physical complaints is high.  Limitations of the study include: the diet is 
very restricted and difficult to create a comparable placebo, parents could not be blinded to the 
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intervention, parents had to pay more attention to their children which, in turn, could improve 
behavior and somatic complaints, sample size is small, and short in time. 
In The Impact of Nutrition on Children with ADHD (INCA) Pelsser et al. (2011) 
investigated the effects of a restricted elimination diet on the behavior of children with attention-
deficit hyperactivity disorder.  The authors conducted a 13-week, randomized, controlled trial to 
test whether ADHD is triggered by foods and to differentiate between non-allergic and allergic 
mechanisms in food induced ADHD. 
 Participants were recruited from medical centers and through media in the Netherlands 
and Belgium.  Inclusion criteria of having diagnosis of ADHD of any subtype, aged 4-8 years 
old, and parents with adequate knowledge of Dutch and who were motivated to follow a 5-week 
restricted elimination diet (RED) was required.  Exclusion criteria were children receiving drugs 
or behavior therapy for ADHD, children already following a diet, or family circumstances that 
were likely to prevent completion of the study.  
 Four questionnaires were used to collect data: the ARS which measured inattention, 
hyperactivity and impulsivity; the ACS measures hyperactivity, impulsivity, attention, mood, and 
temper tantrums; Strengths and Difficulties Questionnaire (SDQ) which measured emotional 
symptoms, conduct, hyperactivity-inattention, and peer problems; and SPI was used to assess 
ODD and conduct disorder.  Unblinded parent and teacher assessments (ACS, ARS, and SPI) 
and blinded pediatrician assessments (ARS and SPI) were conducted to establish baseline and 
again at the end of the first phase.  Blood samples were taken at the start and the end of the first 
phase to evaluate IgE (chicken egg, peanut, soy, milk, fish, and wheat) and IgG (270 different 
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foods) levels using ImuPro test. Each analyzed food was categorized as being a low IgG food or 
a high IgG food. 
 Following baseline assessments, the children were randomly assigned to the diet group or 
the control group and began a 2-week baseline period of not excluding any foods from children's 
diet.  Parents recorded information on diet, behavior, activities, physical complaints, and 
medications in a journal.  The ACS and ARS (parents) and the SDQ (parents and teachers) 
assessments were completed again upon completion of the baseline period.  The start of the first 
phase began at week 4, the diet group started a 5-week RED that consisted of the few foods diet 
(rice, meat, vegetables, pears, and water).  Potatoes, fruits, and wheat were allowed to make the 
intervention easier for parents and children; however, if no changes in behavior were reported, 
the diet was restricted to only the foods in the few foods diet.  At the end of the first phase, 
assessments were completed and blood samples taken.  Participants that had behavior 
improvements of 40% or better on the ARS entered the challenge phase and non-responders left 
the trial. 
 During the second phase (double-blind crossover challenge phase, weeks 10-13) the 
control group continued as it did in the first phase and the responders from the diet group were 
randomized to two food groups (those eating low IgG foods and those eating high IgG foods), 
adding foods from the low IgG or high IgG while continuing the RED based on each child’s IgG 
levels.  Three foods from 270 different foods were added to each child’s diet consecutively for 2 
weeks and managed by a dietician.  All behavioral measurements were double-blind and all 
children were to complete both challenges.  Parent ACS and ARS assessments were completed 
after each challenge; other assessments were completed at weeks 11 and 13 if there was a relapse 
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in behavior.  If no-relapse was reported in the ARS the child continued on to the next challenge. 
Blood samples were collected following a relapse in behavior or at week 13 if no-relapse was 
reported.  
 The ARS and the SPI measurements were calculated kappa values and intra-cluster 
correlation coefficients (ICC).  Kappa values greater than 0.75 (ICC>0.80) were taken to 
represent excellent agreement; values below 0.40 (ICC<0.40) suggests poor agreement.  
Behavior endpoints were assessed using GLM with treatment (diet group vs. control group) 
block, and interactions and baseline scores as covariates.  The correlation between clinical 
response and treatment, and its association with IgE levels was calculated using Fisher’s exact 
test.  The crossover challengers were measured with the Mainland-Gart procedure and the 
Prescott test. 
 From the first phase, 78% of the diet group responded positively with ARS scores 
(blinded pediatrician and unblinded teacher) were significantly lower at the end of the first phase 
than at baseline in comparison to the control group.  Both kappa and ICC scores on the ARS and 
SPI for parent and pediatrician the agreement was greater than 0.40 (mean 0.90) for ICC and 
0.83 for kappa.  ACS scores were also significantly lower in the diet group in comparison to the 
control group for both parent (p<0.0001) and teacher (p<0.0001).  Thirty of 32 responders 
proceeded on to the challenge phase and 19 of the participants showed a relapse after one or both 
challenges.  The decrease in the ARS score from baseline to the end of the first phase was 35.9 
(95% CI 33.2-38.6; p<0.0001) which increased after the challenge by 20.8. The decrease in the 
ACS score from baseline to the end of the first phase was 18.3 (95% CI 16.7-19.9; p<0.0001) 
which increased after the challenge by 11.6.  The control group’s ARS and ACS score did not 
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differ between baseline and the end of the first phase.  Twenty-nine of the 30 responders were 
included in the IgG assessments.  Eleven were assigned to the low-IgG foods challenge and 18 to 
the high-IgG foods challenge.  Each challenge was followed by the other challenge.  Thirteen of 
29 low-IgG and 13 of IgG challenges had a relapse of ADHD behavior.  No relapse was reported 
in 11 of 29.  The order of the challenges was not significantly associated with reported relapse 
(Mainland-Gart p=1.0, Prescott p=0.38).  The IgG type showed no significant effects of high vs. 
low.  
 The RED had significant positive effect on ADHD symptoms in 64% of the children 
participating in the diet group, and reintroducing foods led to a significant relapse in ADHD 
behavior.  IgG blood levels for specific foods did not predict which foods might affect behavior. 
Limitations of the study include: parents and teachers were not blinded to the study.  The clinical 
assessment for the control group was competed at week 13 and the diet group was assessed at 
week 9 which could have revealed to the pediatrician who was participating in the diet group and 
control group.  Behavior improvements in the first phase could have been the result of increased 
attention in the diet group.  To avoid this the control group received education on healthy foods 
and both groups of parents kept journals of their child's participation. 
Pelsser, van Steijn, Frankena, Toorman, Buitelaar, and Rommelse, (2013) conducted a 
randomized controlled pilot study into the effects of a restricted elimination diet on family 
structure in families with ADHD and ODD and whether behavior improvements in the RED 
trials are the result of a difference in parenting structure rather than the diet changes.  
 A subsample of 24 participants (ADHD RED group n=11) (ADHD control group n=13) 
from the INCA study took part in this pilot study.  Inclusion and exclusion criteria for the INCA 
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study were used for selection of participants.  A control group (n=23) was recruited through 
teachers participating in the INCA study children without ADHD aged 4-8. 
The Dutch version of the Family Environment Scale (FES) to measure family 
relationships and structure.  The FES consists of 77 yes/no questions and 7 subscales:  
1) cohesion (family commitment and support), 2) expressiveness (expression of feelings),  
3) conflict (expression of anger and aggression), 4) organization (structure and planning of 
family life), 5) control (rules used in a family life), 6) family values (opinion about norms and 
behavior), and 7) social orientation (involvement in the social environment).  The 18-item 
ADHD DSM-IV Rating Scale (ARS) to assess ADHD and a semi-structured DSM-IV-based, 
psychiatric interview was used as measures in the study.  Two index scores were used in this 
study: the family relationships index (FRI), based on three subscales (cohesion, expressiveness, 
and conflict) and family structure index (FSI), based on two subscales (organization and control). 
The study gathered data at baseline and at the end of the trial in both ADHD groups and 
the non-ADHD control group.  Participants in the ADHD group were randomly assigned to the 
RED group or the ADHD control group.  While the RED group followed the few foods diet 
consisting of rice, meat, vegetables, pears, and water they were also allowed to supplement with 
potatoes, fruits, and wheat to create a less restrictive diet that would be easier to follow for the 
children and their parents.  If no behavior changes were reported the diet was restricted to the 
few foods only.  The ADHD control group received healthy food advice and the non-ADHD 
group received no intervention.  Parents in all groups completed the FES and a blinded 
pediatrician for both the ADHD groups evaluated the ADHD and ODD behavior ratings. 
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The difference between groups values at baseline were obtained using the general linear 
model (GLM) and Cohen’s d was calculated as effect size estimate.  P-values were obtained by 
the Welch-Satterthwaite equation.  FES outcomes at the end of the study were obtained using the 
GLM. ADHD and ODD were analyses were by intention-to-treat and based on blinded 
measurements.  Repeated measurement models were used to separately analyze the moderating 
role of relationship and structure. 
FRI and FSI scores at baseline for the ADHD group and the non-ADHD group were 
similar.  Both ADHD groups had higher scores on the conflict subscale than the no-ADHD 
group.  The effects of RED on ADHD score showed that FRI was significantly associated with 
the ADHD score and an inverse relationship between the number of ADHD symptoms and the 
family relationship: higher ADHD score, the lower the FES Relationships Index score.  There 
was no effect of FSI on ADHD found and changes in both FRI and FSI did not mediate or 
moderate the results of the RED on ADHD symptoms.  Similar results were found for ODD. 
The findings of the study indicate that: 1) the family environment of children with 
ADHD, motivated to follow a 5-week RED, is similar to the family environment of non-ADHD 
and found to be better than norm; 2) family relationship and structure were not affected by the  
5-week RED; 3) the effects of RED on symptoms of ADHD and ODD are not mediated by 
changes in family relationships and structure; and 4) family relationships but not structure were 
inversely associated with ADHD and ODD.  Limitations of the study are that parents knew well 
in advance the strict expectations of the diet.  Parents who would possibly have a hard time 
following the diet would have chosen to not participate and parents who were confident of their 
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parenting capabilities would be more likely to participate.  The sample that participated in the 
study may have had above average family environments.  
Table 3: Summary of Restricted Elimination Diet 
AUTHORS STUDY 
DESIGN 
PARTICIPANTS PROCEDURE FINDINGS 
Pelsser, 
Frankena, 
Toorman, 
Savelkoul, 
Pereira, & 
Buitelaar (2009) 
Quantitative 27 children aged 3.8-
8.5 years that met the 
DSM-IV criteria for 
ADHD Combined 
Type or 
Predominantly 
Inattentive Type 
3 measures were taken 
during a 5-week few 
foods diet that limited 
to few hypoallergenic 
foods. Journals of 
observations, 
abbreviated ten-item 
Conners Scale (ACS) 
and the ADHD Rating 
Scale (ARS). 
Following the trial 
period the 
intervention group 
showed a 62.6% 
improvement on the 
ACS and a 70.3% 
improvement on the 
ARS. The control 
group ACS score 
increases 4.4% and 
decreased ARS by 
2.2%. 
Pelsser, 
Frankena, 
Buitelaar, & 
Rommelse 
(2010) 
Quantitative 24 children aged 3-8 
that met the DSM-IV 
criteria for ADHD 
Combined Type or 
Predominantly 
Hyperactive-
Impulsive Type 
The children 
participating followed 
an elimination diet that 
consisted of limited 
foods from the few 
foods diet and a control 
group for 5 weeks. 
Assessments included 
Physical Complaints 
Questionnaire (PCQ). 
Following the 
elimination diet, 
children showed a 
symptom reduction 
of 77%. 
Parents had to 
provide extensive 
journaling of 
observations and 
symptoms.  
This special 
attention could have 
positive results 
affecting the 
number of 
complaints. 
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Table 3 (continued) 
AUTHORS STUDY 
DESIGN 
PARTICIPANTS PROCEDURE FINDINGS 
Pelsser, 
Frankena, 
Toorman, 
Savelkoul, 
Dubois, Pereira, 
Haagen, 
Rommelse, & 
Buitelaar (2011) 
Quantitative 100 children aged  
4-8 years were 
selected to 
participate in the 
Impact of Nutrition 
on Children with 
ADHD (INCA) 
study. Children met 
DSM-IV criteria for 
ADHD any subtype. 
The study restricted 
foods to the few foods 
diet for 5-weeks and 
used blood tests to test 
for allergies and 
sensitivities to foods. 
The children were 
assessed using ADHD 
Rating Scale (ARS), 
Standard Psychiatric 
Interview (SPI), 
Abbreviated Conners’ 
Scale (ACS) and the 
Strengths and 
Difficulties 
Questionnaire (SQQ). 
 
Blood tests did not 
reveal food 
allergies but 
possible food 
sensitivities in 
elevated IgE levels 
in a few children. 
 
The controls groups 
ARS and ACS 
scores did not 
change across the 
trial. 
 
The diet groups 
ARS (blind 
pediatrician rated) 
and ACS (parent-
rated) scores 
significantly 
decreased from 
baseline. 
Pelsser,  
van Steijn, 
Frankena, 
Toorman, 
Buitelaar, & 
Rommelse 
(2013) 
Quantitative 24 children aged 4-8 
that met DSM-IV 
criteria for ADHD 
that were selected to 
participate in the 
INCA study. 
The study included a 
control group of 23 
without an ADHD 
diagnosis aged 4-8 
years. 
 
Children were 
randomly assigned to 
either a 5-week 
restricted elimination 
diet (RED) (n-11) or a 
control group (n-13) 
that received healthy 
food advice. The 
effects on the family 
environment were 
assessed.  
 
The families were 
given a pre and post 
Family Environment 
Scale (FES) 
assessment. 
 
Families likely to 
participate in a 
RED are likely to 
be similar to the 
families of the 
children without 
ADHD and may 
have consisted of 
above average 
family 
environment. 
 
Family 
relationships and 
the structure were 
not affected by 
following the RED. 
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Chapter 3: Conclusions and Recommendations 
The purpose of this research paper was to evaluate the effectiveness of nutritional 
interventions for treating symptoms of ADHD.  Chapter 1 provided background information on 
the topic, and Chapter 2 presented a review of the research literature.  In this chapter, I discuss 
findings, recommendations, and implications from research findings. 
I reviewed 12 studies that investigate nutritional supplements to reduce symptoms of 
ADHD and the association between foods and additives and symptoms of ADHD in children. 
Six of the 12 studies used supplementation (Bilici et al. 2004; Bos et al., 2015; Gustafsson et al., 
2010; Ko et al., 2014; Konofal, et al., 2008; Lee et al., 2011).  Two studies investigated the 
effects of artificial food additives and food colorings (Bateman et al., 2004; McCann et al; 2007).  
Four studies examined the effects of a restricted/elimination diet (Pelsser et al., 2009; Pelsser  
et al., 2010; Pelsser et al., 2011; Pelsser et al., 2013).  
Six of the 12 studies used supplementation: one study evaluated the effects of zinc sulfate 
(Bilici et al., 2004); one study used an iron supplement (Konofal et al., 2008); two studied fatty 
acids (Bos et al., 2015; Gustafsson et al., 2010), and two studied Korean red ginseng (Ko et al., 
2014; Lee et al., 2011) 
Four of the 12 studies investigated the effects of a restricted/elimination diet.  Two 
studied the effects of the diet on symptoms of ADHD (Pelsser et al., 2009; Pelsser et al., 2011), 
one study assessed the effects of the diet on physical and sleep complaints (Pelsser et al., 2010), 
and one study investigated the effects of the diet on family structure (Pelsser et al., 2013). 
Supplementation of Fatty Acids.  The two studies on the effects of fatty acid 
supplementation for improving symptoms of ADHD showed remarkable improvements for the 
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participating children.  One study examined the effects of EPA and reported a significant 
improvement in inattention/cognitive symptoms (Gustafsson et al., 2010).  Bos et al. (2015) 
reported that children with ADHD with higher levels of DHA were associated with lower 
attention problems at baseline and at follow-up.  In both the Gustafsson et al. (2010) and Bos  
et al. (2015) studies, children with lower levels of PUFA at baseline were the ones to benefit the 
most.  This pattern of improvement with increasing levels of fatty acid suggests that children 
with ADHD might benefit from fatty acid supplementation. 
Supplementation of Vitamins and Minerals. Two studies evaluated the effects of vitamin 
and mineral supplements on the symptoms of children with ADHD.  Bilici et al. (2004) 
examined the effects of zinc sulfate and reported that significant improvements were evident at 
week 4 and maintained through week 12 with hyperactivity, impulsivity, and impaired 
socialization.  Konofal et al. (2008) studied the effects of iron supplementation and suggested 
that a deficiency could be contributing to symptoms of ADHD.  Symptoms on the rating scales 
were significantly reduced after 12 weeks.  
Herbal Supplementation.  The two studies on Korean red ginseng showed remarkable 
improvements for the children participating.  In both the Lee et al. (2011) and Ko et al. (2014) 
studies, a significant difference was found in inattention and hyperactivity/impulsivity 
symptoms.  The results suggest that KRG extract may be an effective and safe alternative 
treatment for inattention and hyperactivity symptoms.  
Food Additives and Colors.  Two studies that examined artificial food additives and food 
colorings commonly found in children’s food.  Bateman et al. (2004) and McCann et al. (2007) 
found that hyperactivity behaviors increased significantly when the children consumed the 
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mixtures containing artificial food colors and sodium benzoate.  The findings of the two studies 
provide evidence of effectiveness that limiting or removing artificial food colorings and sodium 
benzoate might benefit children with symptoms of hyperactivity. 
Diets.  Three studies examined the effects of limiting foods and following a restricted diet 
on symptoms of ADHD such as behavior, physical, and sleep complaints.  Pelsser et al. (2009) 
found that restricting and carefully supervising foods in children significantly improved behavior 
in the participants so much so the majority of the participants no longer met the DSM-IV criteria 
for ADHD.  Pelsser et al. (2010) only measured the effects of a RED diet on physical and sleep 
complaints and found a reduction of 77% for total complaints in the diet group.  Pelsser et al. 
(2011) found that the RED had a significant positive effect on ADHD symptoms in 64% of the 
participants in the diet group, and reintroducing foods led to significant relapse in ADHD 
behavior.  IgG levels for specific foods did not predict which foods might affect behavior. 
Pelsser et al. (2013) investigated the effects of the diet on family structure and found the 
environment of families motivated to participate in a restricted diet are above norm, relationships 
and structure were not affected, the effects of the diet on symptoms were not due to changes in 
family relationships and structure, and family relationships but not structure were inversely 
associated with ADHD. 
Recommendations for Future Research 
 In this section of the review of literature, recommendations for future research based 
upon limitations of the studies in Chapter 2 are discussed.  Overall, small sample sizes were 
problematic in most of the studies, and some did not compare findings to a placebo or control 
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group.  More studies need to be conducted to evaluate the efficacy of nutritional treatments over 
a longer intervention period in order to evaluate long-term effectiveness.  
 With regard to the diet studies, a common limitation noted was that it was not possible to 
blind the parents and teachers, as they were required to prepare food for the participants.  
Another limitation was whether parents willing to participate in a diet study with strict 
expectations would be more confident in their parenting capabilities and have above average 
family environments.  
Implications for Current Practice 
The topic of non-medical treatment is very controversial.  Families may choose non-
medical treatment options in a desperate search for interventions that will alleviate their child’s 
symptoms without putting their health and personalities at risk.  ADHD is one of the most 
common behavioral disorders that continue into adulthood and at this point researchers speculate 
that nutrition plays an important role in symptoms.  
 To date, it has been most commonly treated with psychostimulant drugs and behavior 
therapy.  However, it is critical that providers research, identify, and work with parents to find 
treatment solutions that are effective in treating ADHD and will do more good than harm.  Thus, 
I will continue to advocate for alternative treatment options to prescribing medications to 
children with ADHD. 
Summary 
 The findings of these studies were promising, in that symptoms of ADHD could be 
managed by certain supplements, avoiding artificial food additives and colorings, and/or by 
restricting foods.  Non-medical treatment of ADHD is not new and is sought out in an effort to 
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avoid the negative side effects of prescription medications.  The treatment of ADHD should not 
be considered a one size fits all approach.  Exploring alternative options is critical when 
considering each child’s unique needs.  
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